Borza; Istvan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Borza; Istvan.The latest application filed is for "pharmacologically active alicyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives".

Company Profile

0.10.15

Borza; Istvan - Budapest HU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmacologically active alicyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives Grant 11,026,946 - Borza , et al. June 8, 2	2021-06-08
Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives Grant 10,960,007 - Borza , et al. March 30, 2	2021-03-30
Pharmacologically Active Alicyclic-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives App 20200129515 - BORZA; Istvan ; et al.	2020-04-30
Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives App 20200061068 - BORZA; Istvan ; et al.	2020-02-27
Indole Derivatives App 20130217702 - Beke; Gyula ; et al.	2013-08-22
4-benzyledene-piperidin derivatives Grant 8,008,326 - Borza , et al. August 30, 2	2011-08-30
Benzoyl Urea Derivatives App 20090170901 - Borza; Istvan ; et al.	2009-07-02
Indole-2-carboxamidine derivatives as nmda receptor antago App 20090048303 - Borza; Istvan ; et al.	2009-02-19
Kynurenic Acid Amide Derivatives as Nr2b Receptor Antagoni App 20090012118 - Borza; Istvan ; et al.	2009-01-08
4-Benzyledene-Piperidin Derivatives App 20080312222 - Borza; Istvan ; et al.	2008-12-18
Heterocyclic Carboxylic Acide Amide Derivatives App 20080300276 - Borza; Istvan ; et al.	2008-12-04
Piperidine derivatives as NMDA receptor antagonists Grant 7,435,744 - Domany , et al. October 14, 2	2008-10-14
Amide derivatives as NMDA receptor antagonists Grant 7,378,431 - Horvath , et al. May 27, 2	2008-05-27
Amide derivatives as NMDA receptor antagonists Grant 7,375,116 - Horvath , et al. May 20, 2	2008-05-20
Amide derivatives as NMDA receptor antagonists Grant 7,365,083 - Horvath , et al. April 29, 2	2008-04-29
Amide derivatives as NMDA receptor antagonists Grant 7,361,670 - Horvath , et al. April 22, 2	2008-04-22
Amide derivatives as NMDA receptor antagonists App 20050159451 - Horvath, Csilla ; et al.	2005-07-21
Amide derivatives as NMDA receptor antagonists Grant 6,919,355 - Horvath , et al. July 19, 2	2005-07-19
Amide derivatives as NMDA receptor antagonists App 20050113361 - Horvath, Csilla ; et al.	2005-05-26
Amide derivatives as NMDA receptor antagonists App 20050113359 - Horvath, Csilla ; et al.	2005-05-26
Amide derivatives as NMDA receptor antagonists App 20050113360 - Horvath, Csilla ; et al.	2005-05-26
Piperdine derivatives as NMDA receptor antagonists App 20040157886 - Domany, Gyorgy ; et al.	2004-08-12
N-benzylpiperidine and tetrahydropyridine derivatives Grant 6,657,062 - Kreidl , et al. December 2, 2	2003-12-02
Amide derivatives as NMDA receptor antagonists App 20030199552 - Horvath, Csilla ; et al.	2003-10-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.